Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-01-12

FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for RAMIPRIL (ramipril) from Hikma Pharmaceuticals USA Inc., allowing a generic ramipril product to be marketed under th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)

Snippet

SUPPL AP for RAMIPRIL (RAMIPRIL)